These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8332945)

  • 1. In vivo imaging of monoaminergic nerve terminals in normal and MPTP-lesioned primate brain using positron emission tomography (PET) and [11C]tetrabenazine.
    DaSilva JN; Kilbourn MR; Domino EF
    Synapse; 1993 Jun; 14(2):128-31. PubMed ID: 8332945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain.
    DaSilva JN; Kilbourn MR
    Life Sci; 1992; 51(8):593-600. PubMed ID: 1640810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of [11C]tetrabenazine as an in vivo radioligand for the vesicular monoamine transporter.
    DaSilva JN; Carey JE; Sherman PS; Pisani TJ; Kilbourn MR
    Nucl Med Biol; 1994 Feb; 21(2):151-6. PubMed ID: 9234277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo imaging of vesicular monoamine transporters in human brain using [11C]tetrabenazine and positron emission tomography.
    Kilbourn MR; DaSilva JN; Frey KA; Koeppe RA; Kuhl DE
    J Neurochem; 1993 Jun; 60(6):2315-8. PubMed ID: 8492135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of [11C]tetrabenazine, a vesicular monoamine uptake inhibitor, for PET imaging studies.
    DaSilva JN; Kilbourn MR; Mangner TJ
    Appl Radiat Isot; 1993 Apr; 44(4):673-6. PubMed ID: 8472029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice.
    Kilbourn MR; Kuszpit K; Sherman P
    Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography.
    Gilman S; Koeppe RA; Adams KM; Junck L; Kluin KJ; Johnson-Greene D; Martorello S; Heumann M; Bandekar R
    Ann Neurol; 1998 Sep; 44(3):326-33. PubMed ID: 9749598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cocaine congeners as PET imaging probes for dopamine terminals.
    Brownell AL; Elmaleh DR; Meltzer PC; Shoup TM; Brownell GL; Fischman AJ; Madras BK
    J Nucl Med; 1996 Jul; 37(7):1186-92. PubMed ID: 8965196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of binding sites for 9-fluoropropyl-(+)-dihydrotetrabenazine ([¹⁸F]AV-133) in a MPTP-lesioned PD mouse model.
    Chao KT; Tsao HH; Weng YH; Hsiao IT; Hsieh CJ; Wey SP; Yen TC; Kung MP; Lin KJ
    Synapse; 2012 Sep; 66(9):823-31. PubMed ID: 22623146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PET study of [11C]beta-CIT binding to monoamine transporters in the monkey and human brain.
    Farde L; Halldin C; Müller L; Suhara T; Karlsson P; Hall H
    Synapse; 1994 Feb; 16(2):93-103. PubMed ID: 8197578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Novel Potential Positron Emission Tomography Imaging Agent for Vesicular Monoamine Transporter Type 2.
    Huang ZR; Tsai CL; Huang YY; Shiue CY; Tzen KY; Yen RF; Hsin LW
    PLoS One; 2016; 11(9):e0161295. PubMed ID: 27612194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study.
    Doudet DJ; Rosa-Neto P; Munk OL; Ruth TJ; Jivan S; Cumming P
    Neuroimage; 2006 Mar; 30(1):26-35. PubMed ID: 16378735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Classics in Neuroimaging: Radioligands for the Vesicular Monoamine Transporter 2.
    Kilbourn MR; Koeppe RA
    ACS Chem Neurosci; 2019 Jan; 10(1):25-29. PubMed ID: 30198706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging of VMAT2 binding sites in the brain by (18)F-AV-133: the effect of a pseudo-carrier.
    Zhu L; Qiao H; Lieberman BP; Wu J; Liu Y; Pan Z; Ploessl K; Choi SR; Chan P; Kung HF
    Nucl Med Biol; 2012 Oct; 39(7):897-904. PubMed ID: 22749185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cerebral pharmacokinetics of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as examined by positron emission tomography in a baboon is altered by tranylcypromine.
    Moerlein SM; Stöcklin G; Pawlik G; Wienhard K; Heiss WD
    Neurosci Lett; 1986 May; 66(2):205-9. PubMed ID: 3487753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.
    Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA
    Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo studies of benzisoquinoline ligands for the brain synaptic vesicle monoamine transporter.
    Lee LC; Vander Borght T; Sherman PS; Frey KA; Kilbourn MR
    J Med Chem; 1996 Jan; 39(1):191-6. PubMed ID: 8568807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. REM sleep behavior disorder is related to striatal monoaminergic deficit in MSA.
    Gilman S; Koeppe RA; Chervin RD; Consens FB; Little R; An H; Junck L; Heumann M
    Neurology; 2003 Jul; 61(1):29-34. PubMed ID: 12847152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A PET radiotracer for studying serotonin uptake sites: carbon-11-McN-5652Z.
    Suehiro M; Scheffel U; Dannals RF; Ravert HT; Ricaurte GA; Wagner HN
    J Nucl Med; 1993 Jan; 34(1):120-7. PubMed ID: 8418252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of MPTP on the neuronal uptake of monoamines].
    Burov IuV; Trapkova AA; Malakhova VB; Metkalova SE; Maĭsov NI
    Biull Eksp Biol Med; 1992 Nov; 114(11):492-4. PubMed ID: 1290821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.